Endotoxin, the lipopolysaccharide cell wall constituent of Gram-negative bacteria, produces symptoms of the Gram-negative sepsis syndrome. By measuring endotoxin in blood from septic patients it may be possible to select a subpopulation of patients in which mortality can be prevented by treatment with anti-endotoxin antibodies. We evaluated the performance of an endotoxin-free blood-collectiontube. Within-run and between-run CVs of our endotoxin assay were 4-18% and 8-20%, respectively. In endotoxin-positive samples (LPS 6 ng/L), the concentration of endotoxin in platelet-rich plasma was significantly higher (P <0.001) than in platelet-poor plasma. Apparent binding of endotoxin to platelets ranged from 0% to 92%. The correlation between the apparent percentage binding of LPS to platelets and the platelet count in platelet-rich plasma is linear and positive, but LPS is not bound solely to platelets. We conclude that endotoxin must be measured in platelet-rich plasma. and HDL, high-density lipoprotein.
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Materials and Methods
Patient Selection and Sample Preparation
Patients admitted to the intensive care unit of our hospital and showing signs of a sepsis syndrome according to generally accepted criteria were selected for study (23) . The procedures followed were in accordance with the Helsinki Declaration of 1975, as revised in 1983. Blood was sampled in duplicate in Endo tube ET (Chromogenix, M#{246}lndal, Sweden) at the time the sepsis criteria were met and, later, every 6 h during a 72-h follow-up period (for further details about this tube, see ref.
18). Immediately
after it was withdrawn, the blood was transported to the laboratory. One sample was centrifuged at 4#{176}C for 15 miii at 3000g to obtain PPP. The other sample was centrifuged at 180g for 15 min at 4#{176}C (PRP). After centrifugation the complete plasma layer was separated and then mixed, and platelets were counted in an aliquot of each sample (Sysmex E5000; Toa Medical, Kobe, Japan). A second aliquot was stored at -78#{176}C in sterile polypropylene tubes (Greiner, Frickenhausen, Germany) until measurement. 
Measurement of Endotoxin
Endotoxin in plasma was
Binding of Endotoxin to Platelets
Binding of endotoxin to platelets was estimated as:
Validity of Endotoxin Assay
Stability of endotoxin in human whole blood. Three different quantities of endotoxun standard (E. coli 0111: B4) dissolved in endotoxin-free physiological saline solution were added to blood from healthy volunteers, collected into Endo tubes ET. After the addition of saline and thorough mixing, the samples were either centrifuged directly for preparation of PRP or were incubated for 1 and 2 h at three different temperatures (0, 22, and 3 7#{176}C). After incubation, the incubated samples were also centrifuged to prepare PRP. The PRP samples were stored at -78#{176}C until measurement of endotoxin. Assay precision.
Pooled plasma was obtained from blood of healthy volunteers.
Blood was collected into Endo tubes ET and PRP was prepared. Three different quantities of endotoxun standard dissolved in water were added to three aliquots of this plasma. Plasma dilution was kept constant for each aliquot by addition of water if necessary. After mixing, aliquots of all samples were stored at -78#{176}C until measurement.
Five allquots of each sample were analyzed simultaneously and on five different days for calculation of within-run and between-run precision.
Results
Stability
of endotoxin in whole blood of healthy persons was highest at 0#{176}C and lowest at 37#{176}C (Table 1) , suggesting a temperature-dependent process by which LPS is cleared from the PRP. For example, after 2 h of .g., LPS 6-20 ngfL). Five patients (nos. 1, 4, 7, 8 , and 11) had endotoxin concentrations >20 ng/L (Table  3 ). In most PRP samples with endotoxin at 6 ng/L, endotoxun appeared to be bound to platelets (range 0-92%, Table 3 ). Binding of endotoxin to platelets varied from patient to patient and among samples from a single patient. Two patients had platelet counts <100 x i09/L throughout the follow-up period (nos. 6 and 10); they also had the lowest mean binding of endotoxin to platelets (16% and 14%, respectively; Table 3 ). Mean endotoxin concentrations in PRP were significantly higher (P <0.001, Student's t-test) Fig. 2) . The LPS curve showed two peaks, as did the apparent percentage binding curve.
Discussion
The stability of LPS in normal human blood is adequate at 0#{176}C during a 2-h period (Table 1) . However, it is uncertain whether LPS-positive samples from patients with a sepsis syndrome show the same stability characteristics.
In daily practice, it may be better to cool We found increased concentrations of LPS in all sepsis patients. The patient (no. 11) with positive blood cultures (Pseudomonas aeruginosa) had the highest concentration of LPS (Table 3) . Blood cultures from all other patients were negative.
In two recent studies, the prevalence of endotoxemia in septic patients was 50% and 80% (24, 30). All patients in our study had increased concentrations of endotoxin. This may be explained by the small study population, and by our 72-h follow-up period. Regardless of the results of the blood culture studies, Casey et al. found increased LPS in patients with sepsis (31). Furthermore, all our patients were treated with antimicrobial agents, which may stimulate the release of endotoxin to the bloodstream (32). One patient (no. 3) had LPS concentrations just above our cutoff value of 6 ng/L. Given the precision of our assay at this LPS concentration (i.e., CV = 15%), we estimate the 95% confidence interval ranges from 4.2 to 7.8 ngfL. In 50 of 74 LPSpositive samples ( Our results indicate that significant binding of LPS to platelets occurs in blood from patients with a sepsis syndrome.
We found a positive linear correlation between the apparent percentage binding of LPS to platelets and the PRP platelet count. The LPS measured in PRP was statistically higher than in PPP; this is also documented for LPS from bacteria other than E. coli in in vitro experiments of LPS recovery with normal human blood (20). Data from our patient with the most pronounced endotoxemia suggest that the concentration of LPS in PR? correlates positively with the apparent percentage binding of LPS to platelets (Fig. 2) . However, LPS binds not only to platelets but also to erythrocytes, neutrophils, and monocytes in normal persons and patients with a sepsis syndrome will be necessary to gain further insight into these phenomena.
